Inventor · disambiguated record
Volker Erfle
Also filed as: ERFLE VOLKER
12 granted patents·10 pending applications·233 citations·filing 1990–2012
92Inventor score
Files withGSF FORSCHUNGSZENTRUM UMWELT5SUTTER GERD4HELMHOLTZ ZENTRUM MUENCHEN2BAIER ROBERT1BAVARIAN NORDIC AS1
Top patents by PatentIndex Score
22 records- 0193US6440422B1Recombinant MVA virus, and the use thereofGSF FORSCHUNGSZENTRUM UMWELT·Filed 1998·Granted Aug 27, 2002·104 cites·33 claims
- 0292US8197825B2Recombinant MVA virus and the use thereofSUTTER GERD·Filed 2010·Granted Jun 12, 2012·24 cites·18 claims
- 0388US6682742B1Vector for integration of heterologous sequences into poxviral genomesGSF FORSCHUNGSZENTRUM FUR UNWE·Filed 2000·Granted Jan 27, 2004·32 cites·19 claims
- 0485US7049145B2Vaccinia virus MVA-E3L-knockout-mutants and use thereofGSF FORSCHUNGSZENTRUM UMWELT·Filed 2002·Granted May 23, 2006·23 cites·23 claims
- 0582US7767209B2Modified vaccinia virus Ankara (MVA) mutant and use thereofGSF FORSCHUNGSZENTRUM UMWELT·Filed 2006·Granted Aug 3, 2010·11 cites·15 claims
- 0681US7198934B2Recombinant MVA virus, and the use thereofGSF FORSCHUNGSZENTRUM UMWELT·Filed 2002·Granted Apr 3, 2007·12 cites·34 claims
- 0779US8153138B2Recombinant MVA virusSUTTER GERD·Filed 2006·Granted Apr 10, 2012·2 cites·10 claims
- 0871US7183047B2Reporter gene construct for the detection of HIV Rev and HIV TatGSF FORSCHUNGSZENTRUM UMWELT·Filed 2002·Granted Feb 27, 2007·3 cites·20 claims
- 0961US7150874B2Vector for integration of heterologous sequences into poxviral genomesGFS FORSCHUNGSZENTRUM FUR UMWE·Filed 2003·Granted Dec 19, 2006·1 cites·36 claims
- 1059US2009238843A1Recombinant mva capable of expressing structural hcv antigensSUTTER GERD·Filed 2009·Application pending·0 cites
- 1158US6869793B2Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccinesBAVARIAN NORDIC AS·Filed 1997·Granted Mar 22, 2005·20 cites·5 claims
- 1253US2004265324A1Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccinesFiled 2004·Application pending·0 cites
- 1350US2004137642A1MHC tetramersERFLE VOLKER·Filed 2003·Application pending·0 cites
- 1450US2005287162A1Recombinant fowlpox virusBAIER ROBERT·Filed 2003·Application pending·0 cites
- 1550US2013089569A1Recombinant mva capable of expressing structural hcv antigensHELMHOLTZ ZENTRUM MUENCHEN·Filed 2012·Application pending·0 cites
- 1648US2011293656A1Recombinant mva capable of expressing structural hcv antigensSUTTER GERD·Filed 2011·Application pending·0 cites
- 1745US2005019347A1Recombinant mva capable of expressing structural hcv antigensFiled 2002·Application pending·0 cites
- 1844US2006002896A1Method of generating recombinant MVASTAIB CAROLINE·Filed 2005·Application pending·0 cites
- 1944US2011236409A1Overlapping peptides from variable antigens, t cell populations and uses thereofHELMHOLTZ ZENTRUM MUENCHEN·Filed 2009·Application pending·0 cites
- 2041US2008075694A1MVA vaccineDREXLER INGO·Filed 2007·Application pending·0 cites
- 2123US5582967AHuman cell line LC5 and its useGSF GES FUR STRAHLEN UND UMWEL·Filed 1990·Granted Dec 10, 1996·1 cites·6 claims
- 2214US5770688AMethod and composition for the treatment of mammalian HIV infectionGSF FORSCHUNGSZENTRUM GMBH·Filed 1995·Granted Jun 23, 1998·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →